Repurposing Approved Drugs for Sarcopenia Based on Transcriptomics Data in Humans

Sarcopenia, characterized by age-related loss of muscle mass, strength, and decreased physical performance, is a growing public health challenge amid the rapidly ageing population. As there are no approved drugs that target sarcopenia, it has become increasingly urgent to identify promising pharmaco...

Descripción completa

Detalles Bibliográficos
Autores principales: Liang, Shuang, Liu, Danyang, Xiao, Zhengwu, Greenbaum, Jonathan, Shen, Hui, Xiao, Hongmei, Deng, Hongwen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10145476/
https://www.ncbi.nlm.nih.gov/pubmed/37111364
http://dx.doi.org/10.3390/ph16040607

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10145476/
https://www.ncbi.nlm.nih.gov/pubmed/37111364
http://dx.doi.org/10.3390/ph16040607

Ejemplares similares